These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 3789755

  • 1. [Clinical study of non-Hodgkin's lymphoma--results of the Kanazawa University-Kurume University Cooperative Study on Malignant Lymphomas].
    Nakamura S, Yoshida T, Ohtake S, Itoh K, Kobayashi K, Kanno M, Hirai J, Tachimori K, Matsuda T, Saito Y.
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3440-6. PubMed ID: 3789755
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B, Jancić-Nedeljkov R, Sretenović M, Milivojević G, Janković S, Petrović M.
    Srp Arh Celok Lek; 1998 Dec; 126(9-10):345-8. PubMed ID: 9863405
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM, Graus F, Lopez-Guillermo A, Lewis SA, Villa S, Verger E, Petit J.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):501-8. PubMed ID: 15145169
    [Abstract] [Full Text] [Related]

  • 11. [Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, prednisolone (VEPA) in non-Hodgkin's lymphoma, with special reference to correlation of surface phenotype with response and survival].
    Chubachi A, Miura AB, Yamaguchi A, Nishimura S.
    Gan To Kagaku Ryoho; 1988 Jul 01; 15(7):2057-63. PubMed ID: 3293535
    [Abstract] [Full Text] [Related]

  • 12. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF, Su YS, Liu DG, Jiang WQ, He YJ, Lin TY, Huang HQ, Zhang L, Xia ZJ, Li YH, Zhou ZM, Chen XQ, Xia Y, Zhen ZJ, Guan ZZ.
    Ai Zheng; 2004 Aug 01; 23(8):933-8. PubMed ID: 15301718
    [Abstract] [Full Text] [Related]

  • 13. [Radiotherapy and chemotherapy in stages I and II non-Hodgkin's lymphomas of Waldeyer's ring].
    Hayabuchi N, Jingu K, Miyoshi M, Akasi Y, Masuda K, Komiyama S, Kikuchi M.
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul 20; 25(7):1428-36. PubMed ID: 2212835
    [Abstract] [Full Text] [Related]

  • 14. [Initial anthracycline-based chemotherapy without radiotherapy in patients older than 70 years with localized lymphoma arising from Waldeyer's ring].
    Sampi K, Takagi T, Morii K, Hattori M.
    Gan To Kagaku Ryoho; 1993 Dec 20; 20(15):2345-9. PubMed ID: 8259849
    [Abstract] [Full Text] [Related]

  • 15. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Kamieńska E.
    Ann Acad Med Stetin; 1996 Dec 20; 42():105-22. PubMed ID: 9199116
    [Abstract] [Full Text] [Related]

  • 16. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of non-Hodgkin's lymphoma].
    Yamane T, Hino M, Ohta K, Koh KR, Nakamae H, Aoyama Y, Ota T, Kishida T, Mugitani A, Sannomiya Y, Kamitani T, Takubo T, Tatsumi N.
    Gan To Kagaku Ryoho; 2000 Sep 20; 27(10):1547-55. PubMed ID: 11016000
    [Abstract] [Full Text] [Related]

  • 17. [Clinical analysis of 282 patients with non-Hodgkin's lymphoma].
    Chen SP, Wu DS, Zhao XL.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun 20; 28(3):237-9. PubMed ID: 14653077
    [Abstract] [Full Text] [Related]

  • 18. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
    van Imhoff GW, van der Holt B, Mackenzie MA, Van't Veer MB, Wijermans PW, Ossenkoppele GJ, Schouten HC, Sonneveld P, Steijaert MM, Kluin PM, Kluin-Nelemans HC, Verdonck LF, Dutch-Belgian Hemato-Oncology Cooperative Group.
    J Clin Oncol; 2005 Jun 01; 23(16):3793-801. PubMed ID: 15809447
    [Abstract] [Full Text] [Related]

  • 19. [Clinical significance of immunophenotype in diffuse non-Hodgkin's lymphoma: with special emphasis on the clinical characteristics of T-cell lymphoma].
    Chubachi A, Miura AB, Takatsu H, Yamaguchi A, Nishimura S, Nakayama Y, Akihama T, Miura S, Saitoh M, Watanuki T.
    Gan To Kagaku Ryoho; 1991 Jul 01; 18(8):1303-9. PubMed ID: 2069401
    [Abstract] [Full Text] [Related]

  • 20. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B, Li YX, Fang H, Jin J, Liu XF, Yu ZH.
    Ai Zheng; 2006 Apr 01; 25(4):465-70. PubMed ID: 16613682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.